Bill Cassidy, the leading Republican voice on health care issues, announced his intention to push for a vote this week on a Republican alternative to a...
On December 9, 2025, significant insider activity at Ligand Pharmaceuticals (NASDAQ:LGND) was disclosed as Jason Aryeh, a director at the company, exercised stock options for a...
On December 9, 2025, significant insider activity was reported at Ligand Pharmaceuticals (NASDAQ:LGND) as Jason Aryeh, a Director at the company, exercised stock options for a...
A recent clinical trial has demonstrated that the investigational drug ianalumab, when combined with standard therapy, significantly extends the time to treatment failure for patients suffering...
Patients with immune thrombocytopenia (ITP) who received the investigational drug ianalumab alongside standard therapy experienced significantly longer periods without treatment failure compared to those given a...
A recent phase 1 multicenter study has demonstrated promising safety and efficacy results for a next-generation CAR-T cell therapy known as rapcabtagene autoleucel. This investigational treatment...
Research indicates that the next-generation CAR-T cell therapy, known as rapcabtagene autoleucel, demonstrates significant promise for patients suffering from refractory B-cell acute lymphoblastic leukemia. Data from...
Researchers at Helmholtz Munich have identified a crucial enzyme mutation that acts as a hidden trigger for early-onset dementia. This discovery, published on December 9, 2025,...
A recent study from researchers at **Helmholtz Munich** has identified a rare enzyme mutation that may reveal a critical factor in the onset of dementia. This...
Shares of Option Care Health (NASDAQ: OPCH) received an upgrade from Wall Street Zen, which changed its rating from hold to buy. This announcement came in...
